T

Titan Pharmaceuticals

TTNP

5.58000

USD

-0.42

(-7.00%)

Market Closed

Volume

30

EPS

0

Div Yield

0

P/E

-1

Market Cap

4,214,619

Overview Signals Ideas News

Related Instruments

A

-0.26810

(-30.48%)

0.61160 USD

A

-0.03000

(-2.24%)

1.31000 USD

A

0.05000

(1.87%)

2.73000 USD

A

0

(0%)

0.000000 USD

A

-3.615

(-9.12%)

36.005 USD

A

-0.02500

(-0.45%)

5.52500 USD

B

-0.19000

(-2.61%)

7.10000 USD

B

-0.09000

(-8.04%)

1.03000 USD

C

-0.500

(-0.84%)

59.160 USD

C

-0.60000

(-11.05%)

4.83000 USD

E

-2.160

(-16.99%)

10.550 USD

E

0

(0%)

0.000000 USD

I

0.260

(0.33%)

79.030 USD

K

-0.03000

(-1.03%)

2.88000 USD

M

0

(0%)

0.000000 USD

M

0

(0%)

0.000000 USD

N

11.660

(8.25%)

153.020 USD

0.650

(0.58%)

112.100 USD

P

-0.10000

(-5.24%)

1.81000 USD

R

-0.870

(-1.93%)

44.140 USD

R

-2.000

(-8.26%)

22.200 USD

R

0.260

(2.60%)

10.260 USD

R

0

(0%)

0.000000 USD

S

-0.200

(-1.34%)

14.720 USD

X

-0.05500

(-2.21%)

2.43000 USD

Novo Nordisk Surges in Profit and Sales

5 months ago

Title: Titan Pharmaceuticals

Sector: Healthcare

Industry: Biotechnology

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.